Cargando…
In-vitro inhibition of IFNγ(+) iTreg mediated by monoclonal antibodies against cell surface determinants essential for iTreg function
BACKGROUND: IFNγ-producing CD4(+)CD25(+)Foxp3(+) PBL represent a subtype of iTreg that are associated with good long-term graft outcome in renal transplant recipients and suppress alloresponses in-vitro. To study the mechanism of immunosuppression, we attempted to block cell surface receptors and th...
Autores principales: | Daniel, Volker, Sadeghi, Mahmoud, Wang, Haihao, Opelz, Gerhard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3482559/ https://www.ncbi.nlm.nih.gov/pubmed/22905732 http://dx.doi.org/10.1186/1471-2172-13-47 |
Ejemplares similares
-
Altered expression and editing of miRNA-100 regulates iTreg differentiation
por: Negi, Vinny, et al.
Publicado: (2015) -
TIGIT(+) iTregs elicited by human regulatory macrophages control T cell immunity
por: Riquelme, Paloma, et al.
Publicado: (2018) -
Single-Cell Sequencing Reveals the Transcriptome and TCR Characteristics of pTregs and in vitro Expanded iTregs
por: Hui, Zhenzhen, et al.
Publicado: (2021) -
Cholesterol suppresses human iTreg differentiation and nTreg function through mitochondria-related mechanisms
por: Zhang, Huanzhi, et al.
Publicado: (2023) -
Tumor antigen specific iTreg accumulate in the tumor microenvironment and suppress therapeutic vaccination
por: Schreiber, Taylor H., et al.
Publicado: (2012)